Crossmark

Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study

Crossref DOI link: https://doi.org/10.1186/s12885-019-5889-5

Published Online: 2019-07-09

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Heinrich, Stefan https://orcid.org/0000-0001-9961-0957
Besselink, Marc

Moehler, Markus

van Laethem, Jean-Luc

Ducreux, Michel

Grimminger, Peter

Mittler, Jens

Lang, Hauke

Lutz, Manfred P.

Lesurtel, Mickael
License Information

Text and Data Mining valid from 2019-07-09

Version of Record valid from 2019-07-09
More Information

Article History

Received: 18 February 2019

Accepted: 26 June 2019

First Online: 9 July 2019

Ethics approval and consent to participate

: Does not apply.

: Does not apply

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below